Using protein microarrays to study phosphorylation-mediated signal transduction

Seminars in Cell and Developmental Biology

Volumn 23, Issue 8, 2012, Pages 872-882

  Zhang, Hong ^a   Pelech, Steven ^a,b,c  

^a Kinexus Bioinformatics Corporation   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Brain Research Center   (Canada)

Author keywords

Antibody microarray; Lysate microarray; Phosphosite; Protein kinase; Protein phosphorylation

Indexed keywords

EID: 84868473530     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.05.009     Document Type: Review

References (55)

1. Brognard J., Hunter T. Protein kinase signaling networks in cancer. Current Opinion in Genetics and Development 2011, 21:4-11.
2. Pelech S. Hitting the right kinase targets. BioForum Europe 2008, 12:36-38.
3. Nakamura K.D., Martinez R., Weber M.J. Tyrosine phosphorylation of specific proteins after stimulation of chicken embryo fibroblasts. Molecular and Cellular Biology 1983, 3:380-390.
4. Hunter T., Alexander C.B., Cooper J.A. Protein phosphorylation and growth control. Ciba Foundation Symposium 1985, 116:188-204.
5. Piggee C. Phosphoproteomics: miles to go before it's routine. Analytical Chemistry 2009, 81:2418-2420.
6. Walsh C. Posttranslational modification of proteins: expanding nature's inventory 2006, vol. xxi. Roberts and Co. Publishers, Englewood, CO, p. 490.
7. Mayya V., Han D.K. Phosphoproteomics by mass spectrometry: insights, implications, applications and limitations. Expert Review of Proteomics 2009, 6:605-618.
8. Schulze W. Proteomics approaches to understand protein phosphorylation in pathway modulation. Current Opinion in Plant Biology 2010, 13:280-287.
9. Kosako H., Nagano K. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways. Expert Review of Proteomics 2011, 8:81-94.
10. Ficarro S.B., McCleland M.L., Stukenberg P.T., Burke D.J., Ross M.M., Shabanowitz J., et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nature Biotechnology 2002, 20:301-305.
11. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Science Signaling 2010, 3:ra3.
12. Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:5860-5865.
13. Nita-Lazar A., Saito-Benz H., White F.M. Quantitative phosphoproteomics by mass spectrometry: past, present, and future. Proteomics 2008, 8:4433-4443.
14. Ekins R.P., Chu F.W. Multianalyte microspot immunoassay-microanalytical compact disk of the future. Clinical Chemistry 1991, 37:1955-1967.
15. Knezevic V., Leethanakul C., Bichsel V.E., Worth J.M., Prabhu V.V., Gutkind J.S., et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001, 1:1271-1278.
16. Haab B.B., Dunham M.J., Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biology 2001, 2:1-22.
17. MacBeath G. Protein microarrays and proteomics. Nature Genetics 2002, 32:526-532.
18. Angenendt P., Glökler J., Sobek J., Lehrach H., Cahill D.J. Next generation of protein microarray support materials: evaluation for protein and antibody microarray applications. Journal of Chromatography A 2003, 1009:97-104.
19. Schweitzer B., Roberts S., Grimwade B., Shao W., Wang M., Fu Q., et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nature Biotechnology 2002, 20:359-365.
20. Shao W., Zhou Z., Laroche I., Lu H., Zong Q., Patel D.D., et al. Optimization of rolling-circle amplified protein microarrays for multiplexed protein profiling. Journal of Biomedicine and Biotechnology 2003, 2003:299-307.
21. Chandra H., Reddy P.J., Srivastava S. Protein microarrays and novel detection platforms. Expert Review of Proteomics 2011, 8:61-79.
22. Silvestri A., Colombatti A., Calvert V.S., Deng J., Mammano E., Belluco C., et al. Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Laboratory Investigation 2010, 90:787-796.
23. Sevecka M., Wolf-Yadlin A., MacBeath G. Lysate microarrays enable high-throughput, quantitative investigations of cellular signaling. Molecular and Cellular Proteomics 2011, 10. M110.005363.
24. Mannsperger H.A., Uhlmann S., Schmidt C., Wiemann S., Sahin O., Korf U. RNAi-based validation of antibodies for reverse phase protein arrays. Proteome Science 2010, 8:69.
25. Nielsen U.B., Cardone M.H., Sinskey A.J., MacBeath G., Sorger P.K. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:9330-9335.
26. Gembitsky D.S., Lawlor K., Jacovina A., Yaneva M., Tempst P. A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Molecular and Cellular Proteomics 2004, 3:1102-1118.
27. Ivanov S.S., Chung A.S., Yuan Z.L., Guan Y.J., Sachs K.V., Reichner J.S., et al. Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Molecular and Cellular Proteomics 2004, 3:788-795.
28. Bodet C., Chandad F., Grenier D. Inhibition of host extracellular matrix destructive enzyme production and activity by a high-molecular-weight cranberry fraction. Journal of Periodontal Research 2007, 42:159-168.
29. Massip L., Garand C., Labbé A., Perreault E., Turaga R.V., Bohr V.A., et al. Depletion of WRN protein causes RACK1 to activate several protein kinase C isoforms. Oncogene 2010, 29:1486-1497.
30. Nandy D., Asmann Y.W., Mukhopadhyay D., Basu A. Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes. Journal of Cellular and Molecular Medicine 2010, 14:1396-1407.
31. Bielefeld K.A., Amini-Nik S., Whetstone H., Poon R., Youn A., Wang J., et al. Fibronectin and beta-catenin act in a regulatory loop in dermal fibroblasts to modulate cutaneous healing. Journal of Biological Chemistry 2011, 286:27687-27697.
32. Kozloski G.A., Carraway C.A., Carraway K.L. Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity. Journal of Cellular Physiology 2010, 224:649-657.
33. Dufour A., Zucker S., Sampson N.S., Kuscu C., Cao J. Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides. Journal of Biological Chemistry 2010, 285:35944-35956.
34. Rajala R.V. Phospho-site-specific antibody microarray to study the state of protein phosphorylation in the retina. Journal of Proteomics and Bioinformatics 2008, 1:242.
35. Boehrer S., Adès L., Braun T., Galluzzi L., Grosjean J., Fabre C., et al. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood 2008, 111:2170-2180.
36. Guerrouahen B.S., Futami M., Vaklavas C., Kanerva J., Whichard Z.L., Nwawka K., et al. Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias. Clinical Cancer Research 2010, 16:1149-1158.
37. Millard M., Pathania D., Shabaik Y., Taheri L., Deng J., Neamati N. Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. PLoS One 2010, 5(pii):e13131.
38. 2+ influx extends survival of West Nile virus-infected cells. Journal of Virology 2010, 84:8721-8731.
39. Pelech S., Jelinkova L., Susor A., Zhang H., Shi X., Pavlok A., et al. Antibody microarray analyses of signal transduction protein expression and phosphorylation during porcine oocyte maturation. Journal of Proteome Research 2008, 7:2860-2871.
40. Carter C.A., Misra M., Pelech S. Proteomic analyses of lung lysates from short-term exposure of Fischer 344 rats to cigarette smoke. Journal of Proteome Research 2011, 10:3720-3731.
41. Bhola N.E., Thomas S.M., Freilino M., Joyce S., Sahu A., Maxwell J., et al. Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab. Clinical Cancer Research 2011, 17:4996-5004.
42. Kang S., Elf S., Lythgoe K., Hitosugi T., Taunton J., Zhou W., et al. p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells. Journal of Clinical Investigation 2010, 120:1165-1177.
43. Zhong D., Liu X., Khuri F.R., Sun S.Y., Vertino P.M., Zhou W. LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins. Cancer Research 2008, 68:7270-7277.
44. Paweletz C.P., Charboneau L., Bichsel V.E., Simone N.L., Chen T., Gillespie J.W., et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20:1981-1989.
45. Wulfkuhle J.D., Aquino J.A., Calvert V.S., Fishman D.A., Coukos G., Liotta L.A., et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003, 3:2085-2090.
46. Petricoin E.F., Espina V., Araujo R.P., Midura B., Yeung C., Wan X., et al. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Research 2007, 67:3431-3440.
47. Tibes R., Qiu Y., Lu Y., Hennessy B., Andreeff M., Mills G.B., et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Molecular Cancer Therapeutics 2006, 5:2512-2521.
48. Frederick M.J., VanMeter A.J., Gadhikar M.A., Henderson Y.C., Yao H., Pickering C.C., et al. Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. American Journal of Pathology 2011, 178:548-571.
49. Nanjundan M., Byers L.A., Carey M.S., Siwak D.R., Raso M.G., Diao L., et al. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence. Journal of Thoracic Oncology 2010, 5:1894-1904.
50. Improta G., Zupa A., Fillmore H., Deng J., Aieta M., Musto P., et al. Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation. Journal of Proteome Research 2011, 10:3089-3097.
51. Carvajal-Vergara X., Sevilla A., D'Souza S.L., Ang Y.S., Schaniel C., Lee D.F., et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010, 465:808-812.
52. Jiang R., Mircean C., Shmulevich I., Cogdell D., Jia Y., Tabus I., et al. Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics 2006, 6:2964-2971.
53. Johnson J.J., Syed D.N., Heren C.R., Suh Y., Adhami V.M., Mukhtar H. Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway. Pharmaceutical Research 2008, 25:2125-2134.
54. Kim do J., Park K.S., Kim J.H., Yang S.H., Yoon J.Y., Han B.G., et al. Helicobacter pylori proinflammatory protein up-regulates NF-kappaB as a cell-translocating Ser/Thr kinase. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:21418-21423.
55. Mann M., Ong S.E., Grønborg M., Steen H., Jensen O.N., Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends in Biotechnology 2002, 20:261-268.